Reporting positive treatment outcomes with bendamustine + rituximab in indolent lymphomas
Mathias J Rummel
CLL2-GIVe trial: investigating chemotherapy-free treatment of CLL
Venetoclax: a lifesaving drug for CLL patients
Preliminary results of ibruntinib in combination with FCR chemotherapy for CLL
Importance of Bcl-2-targeted therapies
John Gribben et al.